Inquiry Basket
Azido-PEG3-NHS ester | 1245718-89-1
| Catalog Number | R14-0321 |
| Category | Azides |
| Molecular Formula | C13H20N4O7 |
| Molecular Weight | 344.32 |
| Catalog Number | Size | Price | Quantity |
|---|---|---|---|
| R14-0321 | -- | $-- |
- Worldwide Delivery
- Quality Assurance
- 24/7 Customer Service
Product Introduction
Azido-PEG3-NHS ester is a non-cleavable 3-unit PEG linker that can be used to synthesize antibody-conjugated drugs (ADCs).
Chemical Information |
|
|---|---|
| Related CAS | 1108750-59-9 (polymer) |
| Synonyms | Azido-PEG3-CH2CO2-NHS; N3-PEG3-C2-NHS ester; N3-PEG3-CH2CH2COONHS Ester; 1-[(3-{2-[2-(2-Azidoethoxy)ethoxy]ethoxy}propanoyl)oxy]-2,5-pyrrolidinedione; 2,5-Pyrrolidinedione, 1-[3-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]-1-oxopropoxy]-; N3-PEG3-SPA; Propanoic acid, 3-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]-, 2,5-dioxo-1-pyrrolidinyl ester |
| Purity | ≥98% |
| Shelf Life | ≥12 months if stored properly |
| IUPAC Name | (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]propanoate |
| Canonical SMILES | C1CC(=O)N(C1=O)OC(=O)CCOCCOCCOCCN=[N+]=[N-] |
| InChI | InChI=1S/C13H20N4O7/c14-16-15-4-6-22-8-10-23-9-7-21-5-3-13(20)24-17-11(18)1-2-12(17)19/h1-10H2 |
| InChI Key | BNLXVOZUEBSSRI-UHFFFAOYSA-N |
| Solubility | Soluble in DCM, DMF, DMSO, Water |
| Appearance | Pale Yellow or Colorless Oily Matter |
- Product Specification
| Storage | Store at 2-8°C |
Computed Properties | |
|---|---|
| XLogP3 | -0.4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 14 |
| Exact Mass | 344.13319899 g/mol |
| Monoisotopic Mass | 344.13319899 g/mol |
| Topological Polar Surface Area | 106Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 463 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2023275025-A1 | Conjugates comprising phosphoantigens and their use in therapy | 2021-06-28 |
| WO-2022212958-A1 | Heterobivalent and homobivalent agents targeting fibroblast activation protein alpha and/or prostate-specific membrane antigen | 2021-04-02 |
| US-2021395281-A1 | Macrocyclic chelates and uses thereof | 2020-01-10 |
| US-2022137034-A1 | Detection and quantification of small molecules | 2019-02-25 |
| WO-2020146521-A2 | Rnai agents for inhibiting expression of hif-2 alpha (epas1), compositions thereof, and methods of use | 2019-01-09 |
Applications of Fluorescent Probes & Dyes
Get More Product Details?
